Transcriptomic analysis of the ovarian cancer ascitic microenvironment demonstrated that patients with high levels of phospholipase A2 group VII (PLA2G7), the enzyme that converts phospholipids to AA and leukotriene B4 (LTB4), were associated with a worse outcome as determined by regression-free survival. Here, PLA2G7 is linked to ovarian carcinoma.